Methods for treating bullous pemphigoid by administering an il-4r antagonist
TW202629240APending Publication Date: 2026-07-16REGENERON PHARMACEUTICALS INC +1
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114134374
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-06-18
- Filing Date
- 2025-09-08
- Publication Date
- 2026-07-16
Abstract
Methods for treating bullous pemphigoid in a subject are provided. In one aspect, the methods comprise administering to a subject having bullous pemphigoid one or more doses of an interleukin-4 receptor (IL-4R) antagonist, such as an anti-IL-4R antibody or antigen-binding fragment thereof.
Need to check novelty before this filing date? Find Prior Art